Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Is past exposure to hepatitis A protective against progressive fibrosis in non-alcoholic fatty liver disease?

de Silva AP, Kasturiratne A, Liyanage DL, Karunanayaka TK, de S Hewavisenthi SJ, Dassanayake AS, Farrell GC, de Silva HJ.

Liver Int. 2008 Jan;28(1):147-9. doi: 10.1111/j.1478-3231.2007.01605.x. No abstract available.

PMID:
18173565
2.

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K.

J Gastroenterol Hepatol. 2009 Feb;24(2):248-54. doi: 10.1111/j.1440-1746.2008.05640.x. Epub 2008 Nov 20.

PMID:
19032450
3.

Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.

Yun JW, Cho YK, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Son BH, Shin JH.

Liver Int. 2009 Jul;29(6):878-83. doi: 10.1111/j.1478-3231.2009.01976.x. Epub 2009 Jan 22.

PMID:
19192167
4.

Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.

Pagadala M, Zein CO, McCullough AJ.

Clin Liver Dis. 2009 Nov;13(4):591-606. doi: 10.1016/j.cld.2009.07.011.

PMID:
19818307
5.

[Non-alcoholic steatohepatitis: a controversial cause of liver cirrhosis].

Guilarte López-Mañas J, Bellot García V, Gil Villa MM.

Gastroenterol Hepatol. 1997 Apr;20(4):217. Spanish. No abstract available.

PMID:
9280618
6.

Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.

Ekstedt M, Franzén LE, Holmqvist M, Bendtsen P, Mathiesen UL, Bodemar G, Kechagias S.

Scand J Gastroenterol. 2009;44(3):366-74. doi: 10.1080/00365520802555991.

PMID:
19016382
7.

[Etiologies of liver cirrhosis and their relationships with glucose metabolism disorders in Shanghai].

Xu ZJ, Zhong Y, Fan JG.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):470-1. Chinese. No abstract available.

PMID:
19567033
8.

Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.

Manco M, Bedogni G, Marcellini M, Devito R, Ciampalini P, Sartorelli MR, Comparcola D, Piemonte F, Nobili V.

Gut. 2008 Sep;57(9):1283-7. doi: 10.1136/gut.2007.142919. Epub 2008 Jan 24.

PMID:
18218674
9.
10.

Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.

Vidali M, Occhino G, Ivaldi A, Rigamonti C, Sartori M, Albano E.

Am J Gastroenterol. 2008 Jan;103(1):147-53. doi: 10.1111/j.1572-0241.2007.01596.x.

PMID:
18184121
11.

[Non-alcoholic steatohepatitis. Presentation of a case with development into hepatic cirrhosis].

Valdes Oliveras M, Oristrell Salva J, Allende Monclus E, Bosch Gil JA.

Rev Esp Enferm Apar Dig. 1985 Oct;68(4):363-5. Spanish. No abstract available.

PMID:
4081262
12.

[Etiopathogenesis of liver cirrhosis].

Cerlek S.

Wien Z Inn Med. 1967;48(5):196-203. German. No abstract available.

PMID:
5620280
13.

The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.

Cross TJ, Quaglia A, Hughes S, Joshi D, Harrison PM.

J Viral Hepat. 2009 Jul;16(7):492-9. doi: 10.1111/j.1365-2893.2009.01098.x. Epub 2009 Feb 5.

PMID:
19200134
14.

Cirrhosis of the liver.

Boshnakova T, Gillum RL.

Ethiop Med J. 1972 Oct;10(4):139-44. No abstract available.

PMID:
4669632
15.

Histopathology of non-alcoholic fatty liver disease.

Brunt EM.

Clin Liver Dis. 2009 Nov;13(4):533-44. doi: 10.1016/j.cld.2009.07.008. Review.

PMID:
19818303
16.

Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.

Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, Olgac V, Sonsuz A, Ozbay G, Yurdakul I, Senturk H.

Hepatogastroenterology. 2008 Jul-Aug;55(85):1433-8.

PMID:
18795706
17.

The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.

Kurosaki M, Matsunaga K, Hirayama I, Tanaka T, Sato M, Komatsu N, Umeda N, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Asahina Y, Miyake S, Enomoto N, Izumi N.

J Hepatol. 2008 May;48(5):736-42. doi: 10.1016/j.jhep.2007.12.025. Epub 2008 Feb 26.

PMID:
18329125
18.

Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.

Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, Makaya M, Mizoue T, Kato N, Wickremasinghe AR, de Silva HJ.

J Gastroenterol Hepatol. 2009 Jul;24(7):1284-8. doi: 10.1111/j.1440-1746.2009.05831.x. Epub 2009 May 19.

PMID:
19476560
19.

Aetiological factors of cirrhosis of the liver in Ceylon. (A study of 206 cases).

Rajasuriya K, Thenabadu PN, Wimalaratne KD.

Ceylon Med J. 1970 Jun;15(2):80-7. No abstract available.

PMID:
5494245
20.

Clinical and experimental studies of liver injury in diabetes mellitus. I. Clinical studies.

Takeuchi J, Takada A, Nakada Y, Ebata K.

Acta Hepatosplenol. 1970 May-Jun;17(3):137-51. No abstract available.

PMID:
5421886

Supplemental Content

Support Center